CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
| Revenue (Most Recent Fiscal Year) | $1.31B |
| Net Income (Most Recent Fiscal Year) | $132.42M |
| PE Ratio (Current Year Earnings Estimate) | 13.88 |
| PE Ratio (Trailing 12 Months) | 14.53 |
| PEG Ratio (Long Term Growth Estimate) | 1.80 |
| Price to Sales Ratio (Trailing 12 Months) | 1.43 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.94 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 9.00 |
| Pre-Tax Margin (Trailing 12 Months) | 12.47% |
| Net Margin (Trailing 12 Months) | 10.13% |
| Return on Equity (Trailing 12 Months) | 14.31% |
| Return on Assets (Trailing 12 Months) | 5.64% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.30 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.05 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.94 |
| Inventory Turnover (Trailing 12 Months) | 1.72 |
| Book Value per Share (Most Recent Fiscal Quarter) | $31.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.34 |
| Earnings per Share (Most Recent Fiscal Year) | $4.17 |
| Diluted Earnings per Share (Trailing 12 Months) | $4.24 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 30.91M |
| Free Float | 28.81M |
| Market Capitalization | $1.87B |
| Average Volume (Last 20 Days) | 0.46M |
| Beta (Past 60 Months) | 1.28 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 6.80% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.80 |
| Dividend Yield (Based on Last Quarter) | 1.32% |